These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Dopamine dysregulation syndrome in a patient with Parkinson's disease; a case report]. Hol WM; van der Zwaard R; Hovestadt A; van Megen HJ Tijdschr Psychiatr; 2010; 52(4):259-63. PubMed ID: 20503167 [TBL] [Abstract][Full Text] [Related]
3. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. Klivényi P; Vécsei L Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097 [TBL] [Abstract][Full Text] [Related]
4. Mood swings associated with the 'on-off' phenomenon in Parkinson's disease. Nissenbaum H; Quinn NP; Brown RG; Toone B; Gotham AM; Marsden CD Psychol Med; 1987 Nov; 17(4):899-904. PubMed ID: 3432464 [TBL] [Abstract][Full Text] [Related]
5. Insidious dopamine: provocateur or protective agent in Parkinson's disease? Kostrzewa RM; Brus R; Kostrzewa JP Pol J Pharmacol; 2001; 53(2):165-6. PubMed ID: 11787956 [No Abstract] [Full Text] [Related]
6. Levodopa for the treatment of Parkinson's disease. Lewitt PA N Engl J Med; 2008 Dec; 359(23):2468-76. PubMed ID: 19052127 [No Abstract] [Full Text] [Related]
7. Addiction as aberrant learning-evidence from Parkinson's disease. Dagher A Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132 [No Abstract] [Full Text] [Related]
8. Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause? Coon EA; Laughlin RS J Headache Pain; 2012 Apr; 13(3):255-7. PubMed ID: 22322657 [TBL] [Abstract][Full Text] [Related]
9. Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease. Ricciardi L; Espay KJ; Krikorian R; Fasano A; Espay AJ Parkinsonism Relat Disord; 2016 Jul; 28():152-4. PubMed ID: 27086263 [No Abstract] [Full Text] [Related]
10. Case study: cerebrovascular parkinsonism with levodopa addiction. Lily O; Al-Din A J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1365-6. PubMed ID: 15314141 [No Abstract] [Full Text] [Related]
11. Lees' syndrome: a case series. Becker N; Munhoz RP; Teive HA Arq Neuropsiquiatr; 2011 Oct; 69(5):756-9. PubMed ID: 22042176 [TBL] [Abstract][Full Text] [Related]
16. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline may be toxic in presence of increased dopamine concentrations. Yu PH; Lai CT; Boulton AA BMJ; 1996 Mar; 312(7032):703-4; author reply 704-5. PubMed ID: 8597749 [No Abstract] [Full Text] [Related]
17. [Levodopa dependency in Parkinson's disease: case report and review]. Müller U; Reuter M; Hermann W; Gertz HJ Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883 [TBL] [Abstract][Full Text] [Related]
18. Levodopa-related motor complications--phenomenology. Fox SH; Lang AE Mov Disord; 2008; 23 Suppl 3():S509-14. PubMed ID: 18781677 [TBL] [Abstract][Full Text] [Related]
19. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. Merims D; Giladi N Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927 [TBL] [Abstract][Full Text] [Related]
20. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Evans AH; Katzenschlager R; Paviour D; O'Sullivan JD; Appel S; Lawrence AD; Lees AJ Mov Disord; 2004 Apr; 19(4):397-405. PubMed ID: 15077237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]